Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase

by Savitha C Muppala on  June 3, 2011 at 10:42 PM Cancer News
RSS Email Print This Page Comment
A new drug to treat triple-negative breast cancer is ready to undergo testing.

A group of 15 genes responsible for accelerating the growth of cancer has been found by researchers at the Dana-Farber Cancer Institute in Boston.
 Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase
Novel Drug for Triple-Negative Breast Cancer Enters Testing Phase

This finding has paved the way for clinical trials on a drug which promises to retard or stop the development of triple-negative breast cancer tumors.

Currently, triple negative breast cancers affects more than 40,000 women annually. With these clinical trials, researchers are hoping to arrive at specific therapies to treat triple-negative breast cancers effectively.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive